Clinical Trial Update: NeuroAiD II™ (MLC901) in Mild Traumatic Brain Injury [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for NeuroAiD II (MLC901) in mild traumatic brain injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• NEuroaid II

Snippet

Sponsor: Moleac Pte Ltd. | Conditions: Traumatic Brain Injury | Phase 3 | Status: COMPLETED